Dates: October 12-13, 2012
Location: Los Angeles, CA
Web Page URL: www.hematology.org/Meetings/State-of-the-Art-Symposium/
Topics Covered: Topics will include thrombocytopenia, myelodysplastic syndromes, and lymphoma.
Objectives: This year's program will focus on the newest treatment options for hematologic malignancies with a special focus on thrombosis.
Who Should Attend: Hematologist, Oncologist, Trainees, Alllied Health Professionals, Hematopathologists,hematologist-oncologist
Agenda: The one-and-a-half-day program, held each year, is designed to provide practitioners with an update on advances in the treatment of blood diseases with the intent of addressing educational gaps and improving competence in daily hematology practice. The smaller, clinically focused program format provides attendees with ample opportunities to discuss their actual patient cases and practice challenges with experts in the field. Additionally, in order to enhance the exchange of program content, panel discussions and "lunch with the experts" are included in the meeting content.
Registration Information: Online at www.hematology.org/sas12 Payment by American Express, MasterCard, or Visa is accepted. By Mail Mail the registration form (available at www.hematology.org/sas12) and payment by check only to: ASH Administration P.O. Box 791210 Baltimore, MD 21279-1210 Cancellation Deadline: September 7, 2012 Advanced registraion ends September 7, 2012 For Questions: Contact ASH Customer Relations at 202-776-0544 or email email@example.com.
Fees: Ranges from $135-$450
Continuing Education: Yes
Jun 4, 2013 - Over 90 percent of oncologists in the United States reported that shortages of cancer drugs between March and September 2012 affected patient treatment, forcing them to switch to more expensive drugs and generally compromising patient care, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.
Jun 4, 2013
Dec 13, 2012
Jan 2, 2013
Dec 17, 2012